arrow
M

Massimo Terzolo

University of Turin
H指数:73
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Environmental pollution is associated with poorer survival in patients with adrenocortical carcinoma: findings from a national cohort study in Italy

环境污染与肾上腺皮质癌患者生存率降低相关:来自意大利全国队列研究的结果

2026-09-250
OAAI
Severity and management of hypercortisolism in patients with adrenocortical carcinoma and overt Cushing syndrome

肾上腺皮质癌伴显性库欣综合征患者的重度高皮质醇血症及其管理

2026-09-100
PRE
Metyrapone-associated improvements in health-related quality of life in Cushing's syndrome

美替拉酮改善库欣综合征患者健康相关生活质量

2026-08-310
OAAI
Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial

自动化与手动Ki67标记指数评估对局限性肾上腺皮质癌患者风险分层的影响?——来自ADIUVO试验的经验

Cancers
IF4.4
2026-08-280
OA
EP95 - ECE_2721 - Adrenal masses in advanced cutaneous melanoma: prevalence, clinical features, and prognostic implications in a large retrospective cohort

EP95 - ECE_2721 - 晚期皮肤黑色素瘤中的肾上腺肿块:一项大型回顾性队列研究中的患病率、临床特征及预后意义

2026-08-100
OAAI
Prospective study of metyrapone in endogenous Cushing's syndrome (PROMPT)

内源性库欣综合征中米托坦的前瞻性研究(PROMPT)

2025-09-011
PRE
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial

治疗单侧肾上腺偶发瘤伴轻度自主皮质醇分泌患者的动脉高血压的手术治疗(CHIRACIC):一项多中心、开放标签、优效性随机对照试验

2025-05-120
PRE
Open-label Results From Grace, A Phase 3 Double-blind, Randomized-withdrawal Study Of The Selective Glucocorticoid Receptor Modulator Relacorilant For The Treatment Of Endogenous Hypercortisolism (Cushing Syndrome)
2024-10-050
OAAI